Titre : Amidohydrolases

Amidohydrolases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Logistic Models
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Amidohydrolases : Questions médicales les plus fréquentes", "headline": "Amidohydrolases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Amidohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-19", "dateModified": "2025-03-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Amidohydrolases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hydrolases", "url": "https://questionsmedicales.fr/mesh/D006867", "about": { "@type": "MedicalCondition", "name": "Hydrolases", "code": { "@type": "MedicalCode", "code": "D006867", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "N-acetylmuramoyl-l-alanine amidase", "alternateName": "N-Acetylmuramoyl-L-alanine Amidase", "url": "https://questionsmedicales.fr/mesh/D009238", "about": { "@type": "MedicalCondition", "name": "N-acetylmuramoyl-l-alanine amidase", "code": { "@type": "MedicalCode", "code": "D009238", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.030" } } }, { "@type": "MedicalWebPage", "name": "Allophanate hydrolase", "alternateName": "Allophanate Hydrolase", "url": "https://questionsmedicales.fr/mesh/D000492", "about": { "@type": "MedicalCondition", "name": "Allophanate hydrolase", "code": { "@type": "MedicalCode", "code": "D000492", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.060" } } }, { "@type": "MedicalWebPage", "name": "Formamidase", "alternateName": "Arylformamidase", "url": "https://questionsmedicales.fr/mesh/D005558", "about": { "@type": "MedicalCondition", "name": "Formamidase", "code": { "@type": "MedicalCode", "code": "D005558", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.100" } } }, { "@type": "MedicalWebPage", "name": "Asparaginase", "alternateName": "Asparaginase", "url": "https://questionsmedicales.fr/mesh/D001215", "about": { "@type": "MedicalCondition", "name": "Asparaginase", "code": { "@type": "MedicalCode", "code": "D001215", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.116" } } }, { "@type": "MedicalWebPage", "name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase", "alternateName": "Aspartylglucosylaminase", "url": "https://questionsmedicales.fr/mesh/D001227", "about": { "@type": "MedicalCondition", "name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase", "code": { "@type": "MedicalCode", "code": "D001227", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.125" } } }, { "@type": "MedicalWebPage", "name": "bêta-Lactamases", "alternateName": "beta-Lactamases", "url": "https://questionsmedicales.fr/mesh/D001618", "about": { "@type": "MedicalCondition", "name": "bêta-Lactamases", "code": { "@type": "MedicalCode", "code": "D001618", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cephalosporinase", "alternateName": "Cephalosporinase", "url": "https://questionsmedicales.fr/mesh/D002510", "about": { "@type": "MedicalCondition", "name": "Cephalosporinase", "code": { "@type": "MedicalCode", "code": "D002510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180.229" } } }, { "@type": "MedicalWebPage", "name": "Penicillinase", "alternateName": "Penicillinase", "url": "https://questionsmedicales.fr/mesh/D010405", "about": { "@type": "MedicalCondition", "name": "Penicillinase", "code": { "@type": "MedicalCode", "code": "D010405", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180.697" } } } ] }, { "@type": "MedicalWebPage", "name": "Biotinidase", "alternateName": "Biotinidase", "url": "https://questionsmedicales.fr/mesh/D043523", "about": { "@type": "MedicalCondition", "name": "Biotinidase", "code": { "@type": "MedicalCode", "code": "D043523", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.200" } } }, { "@type": "MedicalWebPage", "name": "Ceramidases", "alternateName": "Ceramidases", "url": "https://questionsmedicales.fr/mesh/D055572", "about": { "@type": "MedicalCondition", "name": "Ceramidases", "code": { "@type": "MedicalCode", "code": "D055572", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Acid Ceramidase", "alternateName": "Acid Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055573", "about": { "@type": "MedicalCondition", "name": "Acid Ceramidase", "code": { "@type": "MedicalCode", "code": "D055573", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.100" } } }, { "@type": "MedicalWebPage", "name": "Alkaline Ceramidase", "alternateName": "Alkaline Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055574", "about": { "@type": "MedicalCondition", "name": "Alkaline Ceramidase", "code": { "@type": "MedicalCode", "code": "D055574", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.300" } } }, { "@type": "MedicalWebPage", "name": "Neutral Ceramidase", "alternateName": "Neutral Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055576", "about": { "@type": "MedicalCondition", "name": "Neutral Ceramidase", "code": { "@type": "MedicalCode", "code": "D055576", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.650" } } } ] }, { "@type": "MedicalWebPage", "name": "Dihydro-orotase", "alternateName": "Dihydroorotase", "url": "https://questionsmedicales.fr/mesh/D004080", "about": { "@type": "MedicalCondition", "name": "Dihydro-orotase", "code": { "@type": "MedicalCode", "code": "D004080", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.280" } } }, { "@type": "MedicalWebPage", "name": "Glutaminase", "alternateName": "Glutaminase", "url": "https://questionsmedicales.fr/mesh/D005972", "about": { "@type": "MedicalCondition", "name": "Glutaminase", "code": { "@type": "MedicalCode", "code": "D005972", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.483" } } }, { "@type": "MedicalWebPage", "name": "Histone deacetylases", "alternateName": "Histone Deacetylases", "url": "https://questionsmedicales.fr/mesh/D006655", "about": { "@type": "MedicalCondition", "name": "Histone deacetylases", "code": { "@type": "MedicalCode", "code": "D006655", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Group III Histone Deacetylases", "alternateName": "Group III Histone Deacetylases", "url": "https://questionsmedicales.fr/mesh/D056545", "about": { "@type": "MedicalCondition", "name": "Group III Histone Deacetylases", "code": { "@type": "MedicalCode", "code": "D056545", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520.200" } } }, { "@type": "MedicalWebPage", "name": "Histone deacetylase 6", "alternateName": "Histone Deacetylase 6", "url": "https://questionsmedicales.fr/mesh/D000073864", "about": { "@type": "MedicalCondition", "name": "Histone deacetylase 6", "code": { "@type": "MedicalCode", "code": "D000073864", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520.350" } } } ] }, { "@type": "MedicalWebPage", "name": "Nicotinamidase", "alternateName": "Nicotinamidase", "url": "https://questionsmedicales.fr/mesh/D009535", "about": { "@type": "MedicalCondition", "name": "Nicotinamidase", "code": { "@type": "MedicalCode", "code": "D009535", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.610" } } }, { "@type": "MedicalWebPage", "name": "Penicillin amidase", "alternateName": "Penicillin Amidase", "url": "https://questionsmedicales.fr/mesh/D010399", "about": { "@type": "MedicalCondition", "name": "Penicillin amidase", "code": { "@type": "MedicalCode", "code": "D010399", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.690" } } }, { "@type": "MedicalWebPage", "name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase", "alternateName": "Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase", "url": "https://questionsmedicales.fr/mesh/D043524", "about": { "@type": "MedicalCondition", "name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase", "code": { "@type": "MedicalCode", "code": "D043524", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.725" } } }, { "@type": "MedicalWebPage", "name": "5-Oxoprolinase(ATP-hydrolysing)", "alternateName": "Pyroglutamate Hydrolase", "url": "https://questionsmedicales.fr/mesh/D011752", "about": { "@type": "MedicalCondition", "name": "5-Oxoprolinase(ATP-hydrolysing)", "code": { "@type": "MedicalCode", "code": "D011752", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.760" } } }, { "@type": "MedicalWebPage", "name": "Urease", "alternateName": "Urease", "url": "https://questionsmedicales.fr/mesh/D014510", "about": { "@type": "MedicalCondition", "name": "Urease", "code": { "@type": "MedicalCode", "code": "D014510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.902" } } } ], "about": { "@type": "MedicalCondition", "name": "Amidohydrolases", "alternateName": "Amidohydrolases", "code": { "@type": "MedicalCode", "code": "D000581", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Rolandas Meškys", "url": "https://questionsmedicales.fr/author/Rolandas%20Me%C5%A1kys", "affiliation": { "@type": "Organization", "name": "Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania." } }, { "@type": "Person", "name": "Yumei Hu", "url": "https://questionsmedicales.fr/author/Yumei%20Hu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } }, { "@type": "Person", "name": "Longhai Dai", "url": "https://questionsmedicales.fr/author/Longhai%20Dai", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Sinofn (Tianjin) Pharmaceutical Technology Co., Ltd, Tianjin 300308, PR China." } }, { "@type": "Person", "name": "Du Niu", "url": "https://questionsmedicales.fr/author/Du%20Niu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } }, { "@type": "Person", "name": "Zhenzhen Xie", "url": "https://questionsmedicales.fr/author/Zhenzhen%20Xie", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Establishment and external validation of an early warning model of diabetic peripheral neuropathy based on random forest and logistic regression.", "datePublished": "2024-09-20", "url": "https://questionsmedicales.fr/article/39304867", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12902-024-01728-9" } }, { "@type": "ScholarlyArticle", "name": "Analysis of the injury severity of motor vehicle-pedestrian crashes at urban intersections using spatiotemporal logistic regression models.", "datePublished": "2023-05-24", "url": "https://questionsmedicales.fr/article/37235968", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.aap.2023.107119" } }, { "@type": "ScholarlyArticle", "name": "Analysing outlier communities to child birth weight outcomes in Malawi: application of multinomial logistic regression model diagnostics.", "datePublished": "2022-11-26", "url": "https://questionsmedicales.fr/article/36435771", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12887-022-03742-z" } }, { "@type": "ScholarlyArticle", "name": "Research and Prediction of Factors Related to High Degree Atrioventricular Block after TAVI Surgery Based on Logistic Regression Model.", "datePublished": "2023-10-25", "url": "https://questionsmedicales.fr/article/37920083", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.59958/hsf.5869" } }, { "@type": "ScholarlyArticle", "name": "Establishment of relapse risk model and multivariate logistic regression analysis on risk factors of relapse in children with primary nephrotic syndrome.", "datePublished": "2022-07-22", "url": "https://questionsmedicales.fr/article/35866787", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MD.0000000000029866" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Hydrolases", "item": "https://questionsmedicales.fr/mesh/D006867" }, { "@type": "ListItem", "position": 5, "name": "Amidohydrolases", "item": "https://questionsmedicales.fr/mesh/D000581" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Amidohydrolases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Amidohydrolases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Amidohydrolases", "description": "Comment diagnostiquer une déficience en amidohydrolases ?\nQuels tests sanguins sont utilisés pour évaluer les amidohydrolases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème d'amidohydrolases ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Amidohydrolases", "description": "Quels sont les symptômes d'une déficience en amidohydrolases ?\nLes troubles métaboliques sont-ils liés aux amidohydrolases ?\nY a-t-il des signes cutanés associés aux troubles enzymatiques ?\nLes symptômes varient-ils selon le type d'amidohydrolase ?\nLes symptômes sont-ils immédiats ou progressifs ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Amidohydrolases", "description": "Peut-on prévenir les troubles liés aux amidohydrolases ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nUne alimentation équilibrée peut-elle prévenir ces troubles ?\nLes vaccinations ont-elles un rôle dans la prévention ?\nL'éducation sur les maladies héréditaires est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Amidohydrolases", "description": "Quels traitements existent pour les déficiences en amidohydrolases ?\nLes médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?\nLa thérapie génique est-elle une option pour ces troubles ?\nLes changements alimentaires peuvent-ils améliorer les symptômes ?\nY a-t-il des traitements naturels pour les troubles d'amidohydrolases ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Amidohydrolases", "description": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?\nLes troubles d'amidohydrolases peuvent-ils affecter la croissance ?\nY a-t-il des risques de maladies auto-immunes ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Amidohydrolases", "description": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?\nL'âge influence-t-il le risque de troubles enzymatiques ?\nLes maladies métaboliques augmentent-elles le risque ?\nLe mode de vie peut-il influencer le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en amidohydrolases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses génétiques peuvent être effectués." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés pour évaluer les amidohydrolases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les dosages enzymatiques dans le sérum peuvent indiquer l'activité des amidohydrolases." } }, { "@type": "Question", "name": "Les biopsies sont-elles nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, des biopsies peuvent être nécessaires pour évaluer l'activité enzymatique." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème d'amidohydrolases ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles digestifs ou métaboliques peuvent signaler une anomalie enzymatique." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications associées." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en amidohydrolases ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs abdominales, des ballonnements et des troubles digestifs." } }, { "@type": "Question", "name": "Les troubles métaboliques sont-ils liés aux amidohydrolases ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une activité enzymatique anormale peut entraîner divers troubles métaboliques." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés aux troubles enzymatiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées peuvent survenir en raison de déséquilibres métaboliques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type d'amidohydrolase ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'enzyme spécifique impliquée." } }, { "@type": "Question", "name": "Les symptômes sont-ils immédiats ou progressifs ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être progressifs, se développant avec le temps en fonction de la déficience." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés aux amidohydrolases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Les tests génétiques peuvent-ils aider à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les personnes à risque de déficiences enzymatiques." } }, { "@type": "Question", "name": "Une alimentation équilibrée peut-elle prévenir ces troubles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé enzymatique, mais ne garantit pas la prévention." } }, { "@type": "Question", "name": "Les vaccinations ont-elles un rôle dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne sont pas directement liées à la prévention des troubles enzymatiques." } }, { "@type": "Question", "name": "L'éducation sur les maladies héréditaires est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation peut aider les familles à comprendre et à gérer les risques associés." } }, { "@type": "Question", "name": "Quels traitements existent pour les déficiences en amidohydrolases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent moduler l'activité enzymatique, mais leur efficacité varie." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour ces troubles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles." } }, { "@type": "Question", "name": "Les changements alimentaires peuvent-ils améliorer les symptômes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation adaptée peut aider à gérer les symptômes liés aux déficiences enzymatiques." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour les troubles d'amidohydrolases ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines approches naturelles peuvent aider, mais il est essentiel de consulter un médecin." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications digestives, métaboliques et neurologiques peuvent se développer." } }, { "@type": "Question", "name": "Les troubles d'amidohydrolases peuvent-ils affecter la croissance ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déficiences enzymatiques peuvent entraîner des retards de croissance chez les enfants." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies auto-immunes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre les troubles enzymatiques et les maladies auto-immunes." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications potentielles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis réguliers avec des professionnels de santé sont essentiels pour surveiller les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies génétiques et des régimes alimentaires déséquilibrés." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de troubles enzymatiques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles enzymatiques se manifestent plus fréquemment à des âges spécifiques." } }, { "@type": "Question", "name": "Les maladies métaboliques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies métaboliques peuvent prédisposer à des déficiences en amidohydrolases." } }, { "@type": "Question", "name": "Le mode de vie peut-il influencer le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie malsain, incluant une mauvaise alimentation, peut augmenter le risque." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes liés aux amidohydrolases." } } ] } ] }

Sous-catégories

23 au total
└─

N-acetylmuramoyl-l-alanine amidase

N-Acetylmuramoyl-L-alanine Amidase D009238 - D08.811.277.087.030
└─

Allophanate hydrolase

Allophanate Hydrolase D000492 - D08.811.277.087.060
└─

Formamidase

Arylformamidase D005558 - D08.811.277.087.100
└─

Asparaginase

Asparaginase D001215 - D08.811.277.087.116
└─

N4-(beta-N-acetylglucosaminyl)-L-asparaginase

Aspartylglucosylaminase D001227 - D08.811.277.087.125
└─

bêta-Lactamases

beta-Lactamases D001618 - D08.811.277.087.180
└─

Biotinidase

Biotinidase D043523 - D08.811.277.087.200
└─

Ceramidases

Ceramidases D055572 - D08.811.277.087.250
└─

Dihydro-orotase

Dihydroorotase D004080 - D08.811.277.087.280
└─

Glutaminase

Glutaminase D005972 - D08.811.277.087.483
└─

Histone deacetylases

Histone Deacetylases D006655 - D08.811.277.087.520
└─

Nicotinamidase

Nicotinamidase D009535 - D08.811.277.087.610
└─

Penicillin amidase

Penicillin Amidase D010399 - D08.811.277.087.690
└─

Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase

Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase D043524 - D08.811.277.087.725
└─

5-Oxoprolinase(ATP-hydrolysing)

Pyroglutamate Hydrolase D011752 - D08.811.277.087.760
└─

Urease

Urease D014510 - D08.811.277.087.902
└─└─

Cephalosporinase

Cephalosporinase D002510 - D08.811.277.087.180.229
└─└─

Penicillinase

Penicillinase D010405 - D08.811.277.087.180.697
└─└─

Acid Ceramidase

Acid Ceramidase D055573 - D08.811.277.087.250.100
└─└─

Alkaline Ceramidase

Alkaline Ceramidase D055574 - D08.811.277.087.250.300
└─└─

Neutral Ceramidase

Neutral Ceramidase D055576 - D08.811.277.087.250.650
└─└─

Group III Histone Deacetylases

Group III Histone Deacetylases D056545 - D08.811.277.087.520.200
└─└─

Histone deacetylase 6

Histone Deacetylase 6 D000073864 - D08.811.277.087.520.350

Sources (10000 au total)

Establishment and external validation of an early warning model of diabetic peripheral neuropathy based on random forest and logistic regression.

The primary objective of this study was to investigate the risk factors for diabetic peripheral neuropathy (DPN) and to establish an early diagnostic prediction model for its onset, based on clinical ... Retrospective data were collected from 1,446 diabetic patients at the First Affiliated Hospital of Anhui University of Chinese Medicine and were split into training and internal validation sets in a 7... A nomogram model was developed using logistic regression with key features: limb numbness, limb pain, diabetic retinopathy, diabetic kidney disease, urinary protein, diastolic blood pressure, white bl... The developed nomogram exhibits promise as an effective tool for the diagnosis of diabetic peripheral neuropathy in clinical settings....

Research and Prediction of Factors Related to High Degree Atrioventricular Block after TAVI Surgery Based on Logistic Regression Model.

Based on the logistic regression model, analyze the risk factors for high degree atrioventricular block after transcatheter aortic valve replacement (TAVI) surgery and further analyze its predictive v... 402 patients who underwent TAVI surgery at Henan Thoracic Hospital for "aortic stenosis" between January 2020 and January 2023 were selected as the study subjects. The study subjects were divided into... The preoperative QRS wave duration in the A group (165.06 ± 61.25) was significantly higher than that in the B group (108.30 ± 16.30), and the difference was statistically significant (p < 0.05). Comp... Preoperative QRS wave duration and Aortic valve calcification score are independent risk factors for high degree atrioventricular block after TAVI, and they have high predictive value. In clinical wor...

Analysis and prediction of older adult sports participation in South Korea using artificial neural networks and logistic regression models.

Korea's aging population and the lack of older adult participation in sports are increasing medical expenses.... This study aimed to segment older adult sports participants based on their demographic characteristics and exercise practice behavior and applied artificial neural network and logistic regression mode... A sample comprising data on 1,770 older adults aged 50 years and above was drawn from the 2019 National Sports Survey. The data were analyzed through frequency analysis, hierarchical and K-means clust... The participants were divided into five clusters. The artificial neural network and logistic analysis models showed that the cluster comprising married women in their 60s who participated in active ex... Targeting women in their 60s who actively participate in sports, the government should expand the supply of local gymnasiums, community centers, and sports programs. If local gymnasiums and community ... This study contributes to the field by providing insights into the specific demographic segments to focus on for measures to reduce medical costs through sports participation....

Significance of logistic regression scoring model based on natural killer cell-mediated cytotoxic pathway in the diagnosis of colon cancer.

The poor clinical accuracy to predict the survival of colon cancer patients is associated with a high incidence rate and a poor 3-year survival rate. This study aimed to identify the poor prognostic b... Based on the expressions and methylations of NKCP-related genes (NRGs) and the clinical information, dimensionality reduction screening was performed to establish a logistic regression scoring model t... This study found that ULBP2 was significantly overexpressed in colon cancer tissues and colon cancer cell lines. The logistic regression scoring model was established to include six statistically sign... The significantly upregulated ULBP2 was a poor prognostic biomarker of colon cancer. The risk score based on the six-feature logistic regression model can effectively predict the 3-year survival time....

Determinants of tobacco use among pregnant women in sub-Saharan Africa. A multilevel mixed-effect logistic regression model.

Although it is known that maternal tobacco use during pregnancy substantially declined in higher-income countries, information on the magnitude and determinants of tobacco use among pregnant women in ... The study used data from Demographic and Health Surveys conducted in 33 countries across SSA from 2010 and 2021. Our analysis included a total weighted sample of 40,291 pregnant women. A multilevel lo... The pooled prevalence of tobacco use among pregnant women in SSA was 1.76% (95% CI: 1.41, 2.12). Our findings showed that pregnant women in the age groups of 25-34 years (AOR 1.44; 95% CI: 1.14, 1.82)... This study revealed that the overall prevalence of maternal tobacco use during pregnancy was relatively low in SSA, but some countries exhibited higher estimates. To address this, it is crucial to imp...

Predicting ipsilateral recurrence in women treated for ductal carcinoma in situ using machine learning and multivariable logistic regression models.

To develop machine learning (ML) and multivariable regression models to predict ipsilateral breast event (IBE) risk after ductal carcinoma in situ (DCIS) treatment.... A retrospective investigation was conducted of patients diagnosed with DCIS from 2007 to 2014 who were followed for a minimum of five years after treatment. Data about each patient were extracted from... 650 women (mean age 56 years, range 27-87 years) underwent treatment for DCIS and were followed for at least five years after treatment (mean 8.0 years). 5.5% (n = 36) experienced an IBE. With multiva... Variables associated with higher IBE risk after DCIS treatment include younger age, dense breasts, and <5 years of adjuvant endocrine therapy. The multivariable logistic regression model attained the ...